Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2013

May 8, 2013

284_dirs_2013-05-08_d31798e5-e101-4546-b569-e7493fa0dddd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2013-05-06

Reporting Person: KELLOGG PETER N (Exe V-P & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-05-07 Common Stock M 37325.0000 $0.0000 Acquired 130985.9020 Direct
2013-05-07 Common Stock F 19354.0000 $44.9800 Disposed 111631.9020 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-05-06 Stock Option (right to buy) $44.9800 A 206119.0000 Acquired 2023-05-05 Common Stock (206119.0000) Direct
2013-05-07 Restricted Stock Unit $ M 37325.0000 Disposed 2013-05-07 Common Stock (37325.0000) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: The option vests in three equal annual installments beginning May 6, 2014.

F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.